Stanford, Neurotrope deal

Stanford granted Neurotrope exclusive, worldwide rights to a process that allows for the accelerated synthesis of the company's bryostatin-1. Neurotrope said obtaining natural bryostatin-1 includes a lengthy purification process and that the synthetic version has cost, time and manufacturing risk reduction benefits. Neurotrope declined to disclose financial terms, and Stanford did not respond to inquiries. ...